Mission
ACTS MISSION IS TO MAKE THE WASHINGTON, DC METROPOLITAN AREA A LEADER IN ADVANCING CLINICAL TRIAL ACCRUAL, THUS ACCELERATING IMPROVED CANCER CARE AND TREATMENT.
Public Charity
ADVANCING CANCER TREATMENT
ADVANCING CANCER TREATMENT is a nonprofit organization categorized as Public Charity based in MOULTONBOROUGH, NH. Its most recent IRS filing (2024) reports revenue of $43K, expenses of $824K, total assets of $714K. Imperigo tracks 6 reported grant relationships connected to this organization totaling approximately $11.2M.
EIN: 832886283
MOULTONBOROUGH, NH
Latest filing: 2024
Total Revenue$43K
Total Expenses$824K
Total Assets$714K
Grant Records6
Funding Total$11.2M
Filing Years2020–2024
Sample Grants Received
For grant recipient's exempt purposes
$4,000,000
For grant recipient's exempt purposes
$2,500,000
For grant recipient's exempt purposes
$2,500,000
For grant recipient's exempt purposes
$800,000
For grant recipient's exempt purposes
$800,000
Showing up to 5 of 6 total records — full history available with membership.
Officers & Directors
DIRECTOR
Adam R Metwalli Md
PRESIDENT, TREASURER
David Brown
DIRECTOR
Donald L Trump Md
DIRECTOR
Jeanny B Aragon-Ching Md
DIRECTOR
Otis W Brawley Md
VICE PRESIDENT, SECRETARY
Pamela Brown
Officer compensation and complete director data available with membership.
Top Grant Purposes
Financial Trends
| Year | Revenue | Expenses | Assets |
|---|---|---|---|
| 2024 | $43K | $824K | $714K |
| 2023 | $2.1M | $1.3M | $1.5M |
| 2022 | $3.0M | $3.1M | $684K |
| 2021 | $1.5M | $820K | $1.2M |
| 2020 | $1.6M | $1.2M | $497K |
Between 2020 and 2024, reported annual revenue declined from $1.6M to $43K (-97%), with total assets most recently reported at $714K.
Interactive year-over-year charts and full filing details available with membership.